These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4898562)

  • 41. [T- and B-lymphocyte count in patients awaiting kidney transplantation and retransplantation].
    Petrova IV; Baeva LB; Vasil'eva LL; Naumtseva SI; Levitskiĭ ER
    Probl Gematol Pereliv Krovi; 1978 Dec; 23(12):14-6. PubMed ID: 364467
    [No Abstract]   [Full Text] [Related]  

  • 42. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
    Sulková S; Lapcík O; Votruba T
    Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Some thoughts about the regular haemodialysis and kidney transplantation programme in our country (author's transl)].
    Smetisko A; Thune S; Grgas J; Jug M
    Lijec Vjesn; 1979 May; 101(5):257-60. PubMed ID: 390279
    [No Abstract]   [Full Text] [Related]  

  • 44. Pentoxifylline does not prevent haemodialysis induced neutropaenia or hypoxaemia.
    Rayner BL; Pascoe MD; Thebus G
    Nephron; 1992; 60(3):363-5. PubMed ID: 1565191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma 25-hydroxy-vitamin D in normal subjects and patients with terminal renal failure, on maintenance haemodialysis and after transplantation.
    Eastwood JB; Daly A; Carter GD; Alaghband-Zadeh J; De Wardener HE
    Clin Sci (Lond); 1979 Nov; 57(5):473-6. PubMed ID: 391471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].
    Starzyk J; Kowalski D
    Wiad Lek; 1993 Apr; 46(7-8):283-5. PubMed ID: 8249416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thyroid function in chronic renal failure, haemodialysis, and transplant patients.
    Frutos M; Casado S; Peces R; Sánchez Martin JA; Hernando ML
    Proc Eur Dial Transplant Assoc; 1978; 15():619-21. PubMed ID: 368792
    [No Abstract]   [Full Text] [Related]  

  • 48. [Morbidity during regular dialysis treatment and after renal transplantation (author's transl)].
    Schmidt P; Balcke P; Kopsa H; Zazgornik J; Deutsch E
    Wien Klin Wochenschr; 1979 Mar; 91(6):193-7. PubMed ID: 371157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Does multiple use of a cuprophan dialyser influence levels of chromium and cadmium during hemodialysis in patients with chronic kidney failure?].
    Małecka J; Grzeszczak W; Zukowska-Szczechowska E; Jendryczko A; Baczyński R
    Pol Arch Med Wewn; 1995 Dec; 94(6):482-7. PubMed ID: 8618810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of recovery from neutropenia induced by hemodialysis.
    Brubaker LH; Nolph KD
    Blood; 1971 Nov; 38(5):623-31. PubMed ID: 5094585
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of dialyser composition and reuse on neutrophil count and elastase alpha-1 proteinase inhibitor complex formation.
    Donovan KL; Pacholok S; Phillips A; Humes JL; Coles GA; Williams JD
    Int J Artif Organs; 1992 Mar; 15(3):139-43. PubMed ID: 1521897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preliminary report on complement activating potential of polycarbonate membrane.
    Henderson LW; Chenoweth DE; Shinaberger JH; Miller J; Konstantin P
    Blood Purif; 1986; 4(1-3):74-81. PubMed ID: 3730164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukotriene release from neutrophils of patients on hemodialysis with cellulose membranes.
    Jörres A; Jörres D; Gahl GM; Schulz E; Mahiout A
    Int J Artif Organs; 1992 Feb; 15(2):84-8. PubMed ID: 1313396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maintenance haemodialysis and renal transplantation.
    Ogg C
    Br Med J; 1970 Nov; 4(5732):412-5. PubMed ID: 4921285
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hematologic changes during extracorporeal dialysis].
    Gazmuri R; Katz E; Gehrung E; Gazmuri P; Saavedra L
    Rev Med Chil; 1971 Oct; 99(10):747-9. PubMed ID: 5139654
    [No Abstract]   [Full Text] [Related]  

  • 56. T-cell subset counts and serum immunoglobulin concentrations in patients with chronic renal failure at the Kenyatta National Hospital.
    Gogo KO; McLigeyo SO; Bwayo JJ; Mumo JM
    East Afr Med J; 1998 May; 75(5):271-3. PubMed ID: 9746996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regular haemodialysis and renal transplantation.
    Crosby DL; Jones JH
    Lancet; 1970 Sep; 2(7672):574-5. PubMed ID: 4195243
    [No Abstract]   [Full Text] [Related]  

  • 59. Lymphocyte subsets in dialyser eluates: a new parameter of bioincompatibility?
    Grooteman MP; Nube MJ; van Limbeek J; Schoorl M; van Houte AJ
    Nephrol Dial Transplant; 1996 Jun; 11(6):1073-8. PubMed ID: 8671971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin.
    Bonomini M; Stuard S; Carreno MP; Settefrati N; Santarelli P; Haeffner-Cavaillon N; Albertazzi A
    Nephron; 1997; 75(4):402-11. PubMed ID: 9127326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.